Arkolith/Insider Trading/PALI/Form 4

Finley John David

CEO, CFO, Director, DirectorPALISADE BIO, INC. (PALI) · full profile →Form 4 · filed May 30, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 28, 2024Tax withholding(F)607$4.76$3K13K
May 28, 2024Tax withholding(F)959$4.76$5K12K
May 28, 2024Option exercise(M)3K—$013K
May 28, 2024Tax withholding(F)467$4.76$2K10K
May 28, 2024Option exercise(M)2K—$010K
May 28, 2024Option exercise(M)2K—$014K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 28, 2024Option exercise(M)2K——0
May 28, 2024Option exercise(M)3K——0
May 28, 2024Option exercise(M)2K——0

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-022037) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for PALISADE BIO, INC.

Build

Ask your agent about PALI insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001493152-24-022037"
Ask your agent
Use Arkolith to summarize insider buying and selling at PALISADE BIO, INC.
over the last 90 days and cite the filings.